Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v2.4.0.8
Condensed Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
 9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Provision for bad debt $ 9 $ 0
Net income (loss) (899) (1,731)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization 922 1,490
Contingent consideration and realignment accrual accretion 106 106
Stock-based compensation 1,519 1,520
Other changes in assets and liabilities:    
Decrease in accounts receivable 6,658 1,368
(Increase) decrease in unbilled costs (4,690) 1,608
Decrease (increase) in other current assets 2,330 (477)
Increase in other long-term assets 0 (6)
Decrease in accounts payable (1,620) (985)
(Decrease) increase in unearned contract revenue (2,483) 368
Increase (decrease) in accrued salaries and bonus 957 (1,263)
Decrease in other accrued expenses (1,620) (3,813)
Decrease in long-term liabilities (952) (1,340)
Net cash provided by (used in) operating activities 237 (3,155)
Cash Flows From Investing Activities    
Purchase of property and equipment (1,648) (528)
Investment in non-controlled entity (1,500) 0
Net cash used in investing activities (3,148) (528)
Cash Flows From Financing Activities    
Cash paid for repurchase of restricted shares (245) (125)
Net cash used in financing activities (245) (125)
Net (decrease) increase in cash and cash equivalents (3,156) (3,808)
Cash and cash equivalents – beginning 52,783 64,337
Cash and cash equivalents – ending $ 49,627 $ 60,529